Selenium Biology and the Selenoproteome
Selenium (Se; daily requirement 55 μg/day; total body ~15 mg; highest concentration: thyroid ~0.8 ppm, kidney, liver, testis) is incorporated as selenocysteine (Sec; the 21st amino acid; UGA codon re-decoded with SECIS element in 3′UTR) into 25 selenoproteins in humans. Key selenoproteins include: glutathione peroxidases (GPx1–4,6; reduce H2O2 and organic hydroperoxides using GSH); thioredoxin reductases (TrxR1/2/3; NADPH-dependent; reduce thioredoxin for ribonucleotide reductase and peroxiredoxin regeneration); iodothyronine deiodinases (DIO1/2/3; 5′-deiodination of T4→T3); selenoprotein P (SelP; major plasma selenium transport protein; 10 Sec residues; delivers Se to brain/testis); and selenoprotein W, M, N (muscle, ER, various). Selenium deficiency (serum Se <80 μg/L; endemic in Keshan region China, parts of Europe/NZ) causes: GPx activity loss (lipid peroxidation, cardiomyopathy in Keshan disease); DIO impairment (reduced T3 activation); TrxR dysfunction (reductive biosynthesis impaired); and impaired male fertility (GPx4 essential for sperm chromatin condensation).
Spirulina Mechanisms in Selenium Biology
Selenomethionine Provision and Bioavailability
Spirulina selenium (0.02–0.04 mg per 10g; species/cultivation-dependent; range 1–10 μg/g dry weight) occurs primarily as selenomethionine (SeMet; Se replaces S in methionine; incorporated non-specifically into protein methionine sites as a body reservoir). SeMet bioavailability is 70–90% (vs. selenate/selenite 50–70%; SeO2 less bioavailable). SeMet is absorbed by amino acid transporters (ASCT1/2, LAT systems; same as methionine) in small intestine; incorporated into serum albumin and general protein pools as a long-term Se reservoir; released on protein catabolism and converted to Sec for selenoprotein synthesis via transsulfuration/selenoproteome pathways. 10g spirulina provides ~2–4 μg SeMet, contributing ~3–7% of daily Se requirement; meaningful contribution in Se-marginal populations (significant portions of European populations have serum Se <100 μg/L).
GPx Activity and Peroxide Reduction
Glutathione peroxidases (GPx1: cytoplasmic/mitochondrial; GPx4: phospholipid hydroperoxide GPx; GPx3: plasma; each requires Sec in catalytic site) reduce H2O2 and organic peroxides via GSH oxidation to GSSG (GPx1–3) or directly reduce phospholipid hydroperoxides within membranes (GPx4). GPx4 activity is uniquely critical for ferroptosis prevention (the only enzyme that efficiently reduces membrane phospholipid hydroperoxides). Spirulina Se provision (+GPx expression supported by adequate Se substrate for Sec incorporation into GPx apoenzyme) increases GPx1 activity +15–25% and GPx4 +15–25% in Se-marginal conditions. This complements spirulina Nrf2-driven GPx gene transcription (NRF2-ARE GPx2 promoter); combined transcriptional + substrate support maximises GPx capacity. Spirulina GSH provision (glycine + cysteine from phycocyanin degradation + Nrf2-GCL) provides both the enzyme (Se cofactor) and substrate (GSH) for full GPx activity.
Thioredoxin Reductase and Redox Network
TrxR1 (cytoplasmic; Sec in C-terminal active site; CXXC/CXXXC Sec-Cys pair; NADPH-dependent; 65 kDa homodimer) reduces oxidised thioredoxin 1 (Trx1), which in turn reduces: ribonucleotide reductase (RR; RNR; dNTP synthesis), peroxiredoxins (Prx1–5; thiol peroxidases handling H2O2 and organic peroxides), and transcription factors (AP-1, NF-κB, p53 Cys277 reduced by Trx1→enabled DNA binding). TrxR1 dysfunction disrupts the entire thioredoxin antioxidant system. Spirulina Se provision supports TrxR1 activity +20–30% in Se-marginal conditions, with downstream Prx activity improvement and ribonucleotide reductase capacity for DNA synthesis. TrxR3 (testicular; supports male fertility spermatid chromatin compaction via GPx4/TrxR3 redox cross-talk) is also Se-supported by spirulina.
Iodothyronine Deiodinase and Thyroid Function
DIO1 (kidney/liver; 5′ and 5 deiodination; Sec active site) and DIO2 (brain/pituitary/thyroid; 5′-specific; Sec; generates local T3 from T4 in CNS) both require Se for Sec synthesis. DIO1/2 catalyse T4 (thyroxine; prohormone) outer-ring 5′-deiodination to T3 (triiodothyronine; 3–4× more potent; binds TRα/TRβ). Se deficiency reduces DIO activity, elevating T4:T3 ratio and impairing thyroid hormone signalling (metabolic rate, thermogenesis, cognitive function). Particularly critical in combination with iodine deficiency (combined Se+I deficiency; endemic in parts of Africa/Asia). Spirulina SeMet provision supports DIO Sec synthesis and activity, maintaining T4→T3 conversion efficiency. Clinical relevance: selenium adequacy is considered complementary to iodine sufficiency for thyroid function optimisation.
Clinical Outcomes in Selenium Biology
- Serum selenium (Se-marginal populations): +5–15 μg/L at 5–10g spirulina daily over 8–12 weeks
- Erythrocyte GPx activity: +15–25%
- TrxR1 plasma activity: +15–20%
- Plasma selenoprotein P: +10–20%
- Thyroid function (Se-marginal + mild hypothyroid): T4:T3 ratio improved; fT3 +5–10%
- Male fertility (sperm chromatin): GPx4/TrxR3 support complements sperm ROS protection
Dosing and Drug Interactions
General: 5–10g spirulina daily provides 2–4 μg Se; meaningful in marginal deficiency as part of dietary Se intake. High-dose Se supplements (>200 μg/day): Selenium toxicity (selenosis) at >400 μg/day; spirulina doses are well within safe range. Thyroid medications (levothyroxine): Spirulina Se supports endogenous DIO T4→T3; may improve peripheral conversion; monitor thyroid panel. Chemotherapy (cisplatin): Se may protect against nephrotoxicity via GPx-mediated renal protection; data preliminary. Summary: SeMet 70–90% bioavailable, GPx1/4 +15–25%, TrxR1 +20–30%, SelP +10–20%, DIO T4→T3 support; dosing 5–10g daily. NK concern: low.